양세훈 교수 연구실
article|
gold
·인용수 17
·2021
Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea
Taeyun Kim, Tae Won Jang, Chang‐Min Choi, Mi‐Hyun Kim, Sung Yong Lee, Cheol‐Kyu Park, Yoon Soo Chang, Kye Young Lee, Seung Joon Kim, Sei Hoon Yang, Jeong‐Seon Ryu, Jeong Eun Lee, Shin Yup Lee, Chan Kwon Park, Sang Hoon Lee, Seung Hun Jang, Seong Hoon Yoon
IF 4.711Cancer Medicine
초록
Sequential afatinib and osimertinib treatment resulted in better survival rates than treatment with afatinib followed by other chemotherapies.
키워드
AfatinibOsimertinibMedicineLung cancerInternal medicineT790MOncologyConfidence intervalProportional hazards modelLog-rank test